Patents by Inventor Marion GAY

Marion GAY has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • USE OF OILS COMPRISING NON-NEUROTOXIC ANTI-WEAR ADDITIVES
    Publication number: 20230242830
    Abstract: Disclosed is a method using at least one anti-wear additive in an oil, the at least one anti-wear additive including at least one polyphosphorus compound to reduce and/or prevent the neurotoxicity of the oil or for the prophylaxis of aerotoxic syndrome, preferably in case of fume event.
    Type: Application
    Filed: May 18, 2021
    Publication date: August 3, 2023
    Inventors: Djibril FAYE, Marion GAY, Florence SEVERAC, Jean-Louis MANSOUX, Grégoire HERVE
  • SPECIFIC ORGANOPHOSPHORUS COMPOUNDS AS NON-NEUROTOXIC ANTI-WEAR AGENTS
    Publication number: 20230183592
    Abstract: Disclosed is the use of specific organophosphorus compounds as anti-wear agents in an oil so as to prevent and/or reduce the neurotoxicity of the oil and/or for the prophylaxis of aerotoxic syndrome in the instance of a fume event.
    Type: Application
    Filed: May 18, 2021
    Publication date: June 15, 2023
    Inventors: Djibril FAYE, Marion GAY, Florence SEVERAC, Grégoire HERVE
  • FLUORESCENT PROBES FOR IDENTIFICATION AND QUANTIFICATION OF HEPATIC TRANSPORTERS IN VITRO AND IN VIVO
    Publication number: 20220308043
    Abstract: Fluorescent probe compounds comprising fluorescent cholic acid derivative are used for visualizing the influence of a candidate compound on biliary excretion in in vitro or in vivo biological models, including certain probes developed report on the activity of the bile salt export pump (BSEP). Visualization is done on hepatocyte cultures with formed bile canaliculi or on liver systems that are exposed to the fluorescent probes and the candidate compound. Visualization is done by fluorescence microscopy. The probes are particularly suitable for early screening of multiple candidate compounds.
    Type: Application
    Filed: March 16, 2022
    Publication date: September 29, 2022
    Inventors: Routier Sylvain, Karen Plé, Marion Gay, Abdelkhalek Ben Jamaa, Christophe Chesné, Ruoya Li, Solenne Martin, Pierre Daligaux
  • Use of oils comprising non-neurotoxic anti-wear additives
    Patent number: 11230683
    Abstract: The invention relates to the use of an oil that does not include tricresyl phosphate and includes as an anti-wear additive at least one diphosphorus compound for the prophylaxis of aerotoxic syndrome, especially in case of fume event. It also relates to the oil as such.
    Type: Grant
    Filed: May 20, 2020
    Date of Patent: January 25, 2022
    Assignee: NYCO
    Inventors: Djibril Faye, Marion Gay, Florence Severac, Jean-Louis Mansoux, Grégoire Herve
  • USE OF OILS COMPRISING NON-NEUROTOXIC ANTI-WEAR ADDITIVES
    Publication number: 20210363455
    Abstract: Disclosed is an oil that does not include tricresyl phosphate and includes as an anti-wear additive at least one diphosphorus compound for the prophylaxis of aerotoxic syndrome, especially in case of fume event. It also relates to a lubrication method utilizing such oil.
    Type: Application
    Filed: May 20, 2020
    Publication date: November 25, 2021
    Inventors: Djibril FAYE, Marion GAY, Florence SEVERAC, Jean-Louis MANSOUX, Grégoire HERVE
  • POLYAMINO BIARYL COMPOUNDS AND THEIR USE
    Publication number: 20210230131
    Abstract: The present invention is directed to novel compounds of Formula I and pharmaceutically acceptable salts or solvates thereof, and their use.
    Type: Application
    Filed: July 10, 2019
    Publication date: July 29, 2021
    Inventors: Patricia MELNYK, Marie TAUTOU, Caroline EVRARD, Florian DESCAMPS, Jamal EL BALKALI, Marion GAY, Nicolas RENAULT, Nicolas SERGEANT, Pascal CARATO, Valérie VINGTDEUX
  • NOVEL 1,4-BIS(3-AMINOPROPYL)PIPERAZINE DERIVATIVE AND ITS USE
    Publication number: 20200407325
    Abstract: The present invention relates to the compound having Formula (I) or pharmaceutically acceptable salts or solvates thereof, and its use in treating and/or preventing a Tauopathy.
    Type: Application
    Filed: September 14, 2020
    Publication date: December 31, 2020
    Inventors: Nicolas SERGEANT, Luc BUEE, Patricia MELNYK, Marion GAY, Nicolas LE FUR
  • 1,4-bis(3-aminopropyl)piperazine derivative and its use
    Patent number: 10807958
    Abstract: The present invention relates to the compound having Formula (I) or pharmaceutically acceptable salts or solvates thereof, and its use in treating and/or preventing a Tauopathy.
    Type: Grant
    Filed: June 15, 2018
    Date of Patent: October 20, 2020
    Assignees: INSERM (Institut National de la Sante et de la Recherche Medicale), UNIVERSITE DE LILLE 2 DROIT ET SANTE
    Inventors: Nicolas Sergeant, Luc Buee, Patricia Melnyk, Marion Gay, Nicolas Le Fur
  • NOVEL 1,4-BIS(3-AMINOPROPYL)PIPERAZINE DERIVATIVE AND ITS USE
    Publication number: 20180290981
    Abstract: The present invention relates to the compound having Formula (I) or pharmaceutically acceptable salts or solvates thereof, and its use in treating and/or preventing a Tauopathy.
    Type: Application
    Filed: June 15, 2018
    Publication date: October 11, 2018
    Inventors: Nicolas SERGEANT, Luc BUEE, Patricia MELNYK, Marion GAY, Nicolas LE FUR
  • 1,4-bis(3-aminopropyl)piperazine derivative and its use
    Patent number: 10017476
    Abstract: The present invention relates to the compound having Formula (I) or pharmaceutically acceptable salts or solvates thereof, and its use in treating and/or preventing a Tauopathy.
    Type: Grant
    Filed: March 16, 2016
    Date of Patent: July 10, 2018
    Assignees: INSERM (Institut National de la Sante et de la Recherche Medicale), CENTRE HOSPITALIER REGIONAL ET UNIVERSITAIRE DE LILLE (CHRU), UNIVERSITE DE LILLE 2 DROIT ET SANTE
    Inventors: Nicolas Sergeant, Luc Buee, Patricia Melnyk, Marion Gay, Nicolas Le Fur
  • NOVEL 1,4-BIS(3-AMINOPROPYL)PIPERAZINE DERIVATIVE AND ITS USE
    Publication number: 20180072679
    Abstract: The present invention relates to the compound having Formula (I) or pharmaceutically acceptable salts or solvates thereof, and its use in treating and/or preventing a Tauopathy.
    Type: Application
    Filed: March 16, 2016
    Publication date: March 15, 2018
    Applicants: INSERM ( Institut National de la Sante et de la Recherche Medicale), CENTER HOSPITALIER REGIONAL ET UNIVERSITAIRE DE LILLE (CHRU), UNIVERSITE DE LILLE 2 DROIT ET SANTE
    Inventors: Nicolas SERGEANT, Luc BUEE, Patricia MELNYK, Marion GAY, Nicolas LE FUR